Skip to main content

Advertisement

SpringerLink
Log in

Health Related Quality of Life in Patients with Cirrhosis

  • Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section editors)
  • Published:
Current Hepatology Reports Aims and scope Submit manuscript

Abstract

HRQOL is a multidimensional concept that usually includes self-report of the way in which physical, emotional, social, or other domains of well-being are affected by a disease or its treatment. The concept of HRQOL is a direct descendent of the World Health Organization definition of health in that HRQOL is thought to encompass multiple domains: (1) biological functioning, (2) psychological functioning, and (3) social functioning. Cirrhosis of the liver has a considerable negative impact on HRQOL. This paper describes the instruments that can be used to measure HRQOL in patients with cirrhosis, factors associated with poor HRQOL, and interventions that may result in improvement in HRQOL for patients with cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Marchesini G, Bianchi G, Amodio P, et al. Italian Study Group for quality of life in cirrhosis. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120(1):170–8.

    Article  CAS  PubMed  Google Scholar 

  2. Les I, Doval E, Flavià M, et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol. 2010;22(2):221–7.

    Article  PubMed  Google Scholar 

  3. Bajaj JS, Thacker LR, Wade JB, et al. PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment PharmacolTher. 2011;34(9):1123–32. Bajaj et al. recently reported data that support the validity and reliability of PROMIS instruments in measuring health status of patients with cirrhosis. In this study, 100 cirrhosis patients and 100 caregivers were asked to complete thePROMIS tools as well as Sickness Impact Profile (SIP) concurrently. Cirrhosis patients had significant impairment inPROMIS domains (depression; fatigue; pain-behaviour; pain-interference; physical function; satisfaction with discretionary social activities; satisfaction with social roles; sleep disturbance; and sleep-related impairment) compared to their caregivers and the US norms (P < 0.02 to <0.0001). Decompensated patients had significantly worse sleep, pain, social and physical function scores compared with compensated ones, similar to legacy instruments. PROMIS tools had significant test - retest reliability (ICC range 0.759–0.985) when administered 12 ± 6 days apart. Most patients preferred PROMIS over SIP.

  4. Gralnek IM, Hays RD, Kilbourne A, et al. Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease–the LDQOL 1.0. Am J Gastroenterol. 2000;95:3552–65.

    CAS  PubMed  Google Scholar 

  5. Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol. 2004;99:1726–32.

    Article  PubMed  Google Scholar 

  6. Younossi ZM, Guyatt G, Kiwi M, et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45(2):295–300.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Reeve BB, Hays RD, Bjorner JB, et al. PROMIS Cooperative Group. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 Suppl1):S22–31.

    Article  PubMed  Google Scholar 

  8. Kanwal F, Gralnek IM, Hays RD, et al. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7(7):793–9.

    Article  PubMed  Google Scholar 

  9. Nardelli S, Pentassuglio I, Pasquale C, Ridola L, Moscucci F, Merli M, et al. Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients. Metab Brain Dis. 2013;28:239–43.

    Article  CAS  PubMed  Google Scholar 

  10. Prakash RK, Kanna S, Mullen KD. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis. ClinTher. 2013;35:1458–73. This comprehensive review describes the effect of minimal hepatic encephalopathy on patients (including their HRQOL burden), as well as its currently available diagnostic and treatment options.

  11. Ahluwalia V, Wade JB, Thacker L, Kraft KA, Sterling RK, Stravitz RT, et al. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. J Hepatol. 2013;59:467–73. This study examined the effect of serum sodium on HRQOL in 82 patients with cirrhosis and found a statistically significant negative correlation between sodium levels and patients’ HRQOL as measured by the Sickness Impact Profile. Patients with hyponatremia, both with and without prior hepatic encephalopathy, had a significantly worse compared to patients with normal serum sodium.

  12. Younossi ZM, McCormick M, Price LL, et al. Impact of liver transplantation on health-related quality of life. Liver Transpl. 2000;6:779–83.

    Article  CAS  PubMed  Google Scholar 

  13. Kanwal F, Spiegel BM, Hays RD, Durazo F, Han SB, Saab S, et al. Prospective validation of the short form liver disease quality of life instrument. Aliment Pharmacol Ther. 2008;28(9):1088–101.

    Article  CAS  PubMed  Google Scholar 

  14. Duffy JP, Kao K, Ko CY, Farmer DG, McDiarmid SV, Hong JC, et al. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg. 2010;252:652–61.

    PubMed  Google Scholar 

  15. Desai R, Jamieson NV, Gimson AE, Watson CJ, Gibbs P, Bradley JA, et al. Quality of life up to 30 years following liver transplantation. Liver Transpl. 2008;14:1473–9.

    Article  PubMed  Google Scholar 

  16. Sanyal A, Younossi ZM, Bass NM, Mullen KD, Poordad F, Brown RS, et al. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2011;34:853–61.

    Article  CAS  PubMed  Google Scholar 

  17. Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol. 2011;106:307–16. Treatment of minimal hepatic encephalopathy may not only improve the neuropsychometric test performance but also have a beneficial effect on patients’ HRQOL. In this randomized, double-blind, placebo-controlled trial, patients with cirrhosis confirmed as having minimal hepatic encephalopathy were randomly assigned to receive either rifaximin (1200 mg/d or placebo for 8 weeks. Rifaximin significantly improved HRQOL at week 8 relative to baseline. Moreover, improvement in HRQOL correlated with improvement in neuropsychologic test scores at week 8.

  18. Wigg AJ, McCormick R, Wundke R, Woodman RJ. Efficacy of a chronic disease management model for patients with chronic liver failure. ClinGastroenterolHepatol. 2013;11(7):850–8. In many chronic disease (including cirrhosis), the need for new and coordinated or collaborative models of care is becoming more evident. This recent pilot study implemented and tested a collaborative care model for general management of patients with decompensated cirrhosis (i.e., patients who are at a particularly high risk for poor HRQOL). The key elements of the intervention included care coordination by nurses who worked in close collaboration with a multidisciplinary team of providers and educating and empowering patients to improve self-management. Patients randomized to the intervention arm reported significant improvement in HRQOL at the end of 12 month follow up. These data show that HRQOL is a modifiable outcome that is amenable to several treatment strategies in patients with cirrhosis.

  19. Planas R, Montoliu S, Balleste B, et al. Natural history of patients hospitalized for management of cirrhotic ascites. ClinGastroenterol Hepatol. 2006;4:1385–94.

    Article  Google Scholar 

  20. García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370–9.

    Article  PubMed  Google Scholar 

  21. Villa E, Cammà C, Marietta M, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology. 2012;143:1253–60.

    Article  CAS  PubMed  Google Scholar 

  22. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This material is based upon work supported in part by the Houston VA HSR&D Center of Excellence (HFP90-020).

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Fasiha Kanwal declares no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Author information

Authors and Affiliations

  1. Clinical Epidemiology and Outcomes Program, Houston VA Health Services Research and Development Center of Excellence, Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, 2002 Holcombe Blvd. (152), Houston, TX, 77030, USA

    Fasiha Kanwal

  2. Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA

    Fasiha Kanwal

Authors
  1. Fasiha Kanwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fasiha Kanwal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanwal, F. Health Related Quality of Life in Patients with Cirrhosis. Curr Hepatology Rep 13, 8–13 (2014). https://doi.org/10.1007/s11901-014-0218-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11901-014-0218-6

Keywords

Search

Navigation